Arca Biopharma reported $14K in Ordinary Share Capital for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
Arca Biopharma ABIO:US USD 14K 0
Biogen BIIB:US USD 100K 0
Brainstorm Cell Therapeutics BCLI:US USD 12K 0
Bristol Myers Squibb BMY:US USD 292M 0
Capricor Therapeutics CAPR:US USD 25K 1000
Cytokinetics CYTK:US USD 93K 8K
Cytrx CYTR:US USD 43.48K 4.7K
Daiichi Sankyo 4568:JP JPY 50B 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Laboratory Of America LH:US USD 8.2M 100K
Myriad Genetics MYGN:US USD 800K 0
Otsuka Holdings 4578:JP JPY 81.69B 0
United Therapeutics UTHR:US USD 700K 0